DeepLife

DeepLife is a biotechnology company that develops digital twins of cells for drug discovery( The company uses state-of-the-art multi-omics data( artificial intelligence( and systems engineering to identify molecular triggers that drive diseased cells back to their healthy state( The platform offers OmicStore for multi-omics data management( Cell Blueprint for cellular modeling( and a TechDemo for demonstration purposes( DeepLife's approach enables researchers to map life one cell at a time( creating computational models that simulate cellular behavior for drug target identification and therapeutic intervention( The company's tools use machine learning technology to process biological data( perform genomic screening( and provide insights into target proteins for individual patient treatments( Founded in 2019 and headquartered in Paris( France( the company has raised $16.4M in Series A funding from investors including YZR Capital( Beiersdorf( Groupe Prunay( Turenne Groupe( Paris Business Angels( Mid Atlantic Bio Angels( Entrepreneur First( Kima Ventures( Super Capital( and Nord Capital Partenaires.